-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
COVID-19
-
Economics of Locally Advanced Lung Cancer Before and During COVID-19 Pandemic: A Perspective for Developing Countries
Since December 2019, the world has been mired in a pandemic that has displaced other 21st-century health priorities for many populations. The social significance and speed of contagion from COVID-19 have altered criteria for public health prioritization, to the detriment of other health problems including noncommunicable diseases, which are recognized as the leading cause of…
-
Losing the Personal Touch in the Digital World
By Rebecca Matthias, MD Posted: June 10, 2020 Ms. Matthias is a patient with lung cancer who, along with so many, has transitioned to telehealth. Ms. Matthias lives in Oshkosh, Wisconsin, but she typically travels to Michigan for her preferred provider. Below are her thoughts on the success of patient–physician communication during the COVID-19…
-
Adapting to the New Virtual Environment: Telehealth Can Be a Patient-First Approach
By Brendon Stiles, MD Posted: June 10, 2020 Imagine living in a city with more than 180,000 reported cases of COVID-19 and more than 24,000 deaths. Next imagine asking your patients with lung cancer to come into the heart of that city, to a hospital that has cared for hundreds of those patients infected…
-
Telehealth Is Not a One-Size-Fits-All Approach
By Narjust Duma, MD Posted: June 10, 2020 During the past 8 weeks, we have heard how many of our colleagues and cancer centers are switching to telehealth. Two things are clear during this pandemic. The first is that cancer centers cannot wait—most cancer procedures and treatments are not elective, and our patients need their…
-
Patient, Provider Safety Paramount During Pandemic: Telehealth Benefits Are Numerous
By Mary Jo Fidler, MD Posted: June 10, 2020 Healthcare systems in the United States have been slow to adopt telehealth, in part, due to regulatory limitations, patient privacy concerns, and less reimbursement potential.1 However, at the same time, there has been an enormous effort to incorporate electronic health records (EHR) driven by programs…
-
TERAVOLT: Global Registry Investigates Outcomes Among Patients With Thoracic Cancer and COVID-19
By Marina Chiara Garassino, MD, and Leora Horn, MD, MSc, FRCPC Posted: June 9, 2020 Marina Chiara Garassino Leora Horn The new SARS-CoV-2 (COVID-19) virus appeared at the end of December 2019 in Wuhan, China, and soon spread globally. In February 2020, the first cases appeared in Europe, and in…
-
Telehealth Successes and Challenges
Posted: June 9, 2020 Across specialties, COVID-19 has resulted in increased patient anxiety and decreased in-person appointments. The rapid uptake of telehealth has, for some, widened disparity gaps and been an obstacle in maintaining patient–physician relationships; for others, telehealth has presented an opportunity to provide consistent long-term care to patients in the safety and comfort…
-
Member Story: Dr. Noemi Reguart
Dr. Noemi Reguart is a medical oncologist at the Hospital Clínic in Barcelona, Spain. In Spain, these past few weeks have been difficult—especially for health care personnel. The coronavirus took off fast, and we had very little time to prepare. Luckily, the government implemented the state of alarm quickly, and after 51 days of confinement,…
-
Impact of COVID-19 on the Diagnostic Workup of Lung Cancer
The COVID-19 pandemic has created numerous challenges with the management of lung cancer, not the least of which is the initial diagnosis. The computer tomography scans, typically used in the diagnostic workup, can be obfuscated by the COVID-19 radiologic features therefore this webinar will discuss the best practices on how to distinguish the two. Bronchoscopic…
-
Systemic Therapy for Advanced Stage Lung Cancer During the COVID-19 Pandemic
Watch Recording IASLC faculty members from Europe, Asia and North America will discuss systemic therapies including chemotherapy, immunotherapy, and targeted therapy for advanced-stage lung cancer during the COVID-19 global pandemic. The faculty will share their experience and advice on 1) how COVID-19 impacts their patient population, 2) changes made in the management of current and…